Wellcome Leap
Wellcome Leap builds bold, unconventional programs, and funds them at scale. Programs that aim to deliver breakthroughs in human health over 5 – 10 years and demonstrate seemingly impossible results on seemingly impossible timelines. Wellcome Leap is a global ARPA for health.
The Wellcome Leap R3 program, jointly funded with CEPI, aims to increase access to biologics development in non-emergency times and to create economically sustainable, equitably distributed surge capacity in pandemic emergency (20B vaccine doses/month).
